Neobiolabsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2024-01-18
Share capital
5 000,00 PLN
Activity description

Neobiolab offers individual genetic testing and consultations to help explain how genes affect metabolism, immunity, beauty, sport and lifestyle. The company develops personalized supplement formulas and recommendations supporting energy, recovery, physical performance and everyday functioning.

Registered address
Aleja Jana Pawła II 27, 00-867 Warszawa, Poland
Website
neobiolab.plWebsite active
Phone

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.19kMedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD -5.98kMedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 7.17kMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 7.05kMedianUSD 119.99kAverageUSD 2.73m

Bank accounts

Registered as a VAT taxpayer on 2024-03-01. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Ewa Beata Beck – President of the Management Board
Paweł Rusin – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Ewa Beata Beck (29)
5$675.3150%
Paweł Rusin (43)
5$675.3150%

Beneficial owners

Person

Competitors

Name
Vitagenumsp. z o.o.
Microbiota Medsp. z o.o.

Change history

DateEvent
2026-07-01Business suspended
2024-01-18Entered in the register

FAQ

Last updated: 2026-07-17